Gene · 8720
Papers2,858
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,858
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Safety and efficacy of vaccinations in patients with multiple sclerosis: a systematic review. | Eur Rev Med Pharmacol Sci | 2024 | 39229847 | PubTator, text mining | PubMed |
| A CRISPR-dCas13 RNA-editing tool to study alternative splicing. | Nucleic Acids Res | 2024 | 39162234 | PubTator, text mining | PubMed |
| Advances in psoriasis research: From pathogenesis to therapeutics. | Life Sci | 2024 | 39153596 | PubTator, text mining | PubMed |
| Retraction. | Biofactors | 2024 | 39118364 | PubTator, text mining | PubMed |
| Making a difference. | Eur J Transl Myol | 2024 | 39105478 | PubTator, text mining | PubMed |
| SPRING licenses S1P-mediated cleavage of SREBP2 by displacing an inhibitory pro-domain. | Nat Commun | 2024 | 38977690 | PubTator, text mining | PubMed |
| Discovery of Potent, Orally Bioavailable Sphingosine-1-Phosphate Transporter (Spns2) Inhibitors. | J Med Chem | 2024 | 38952222 | PubTator, text mining | PubMed |
| Gynotoxic Effects of Chemotherapy and Potential Protective Mechanisms. | Cancers (Basel) | 2024 | 38927992 | PubTator, text mining | PubMed |
| Cystathionine γ-lyase-derived H2S negatively regulates thymic egress via allosteric inhibition of sphingosine-1-phosphate lyase. | Acta Pharmacol Sin | 2024 | 38914678 | PubTator, text mining | PubMed |
| Discovery and biological evaluation of biaryl acetamide derivatives as selective and in vivo active sphingosine kinase-2 inhibitors. | Eur J Med Chem | 2024 | 38875809 | PubTator, text mining | PubMed |
| Endothelial cell sphingosine 1-phosphate receptor 1 restrains VE-cadherin cleavage and attenuates experimental inflammatory arthritis. | JCI Insight | 2024 | 38855867 | PubTator, text mining | PubMed |
| SphK1 deficiency ameliorates the development of atherosclerosis by inhibiting the S1P/S1PR3/Rhoa/ROCK pathway. | Cell Signal | 2024 | 38852936 | PubTator, text mining | PubMed |
| Effects of Phosphorylation on Protein Backbone Dynamics and Conformational Preferences. | J Chem Theory Comput | 2024 | 38830621 | PubTator, text mining | PubMed |
| SPRING is a Dedicated Licensing Factor for SREBP-Specific Activation by S1P. | Mol Cell Biol | 2024 | 38747374 | PubTator, text mining | PubMed |
| Sphingosine-1-phosphate receptor 1/5 selective agonist alleviates ocular vascular pathologies. | Sci Rep | 2024 | 38678148 | PubTator, text mining | PubMed |
| An overview of sphingosine-1-phosphate receptor 2: Structure, biological function, and small-molecule modulators. | Med Res Rev | 2024 | 38665010 | PubTator, text mining | PubMed |
| Apelin-13: a novel approach to suppressing renin production in RVHT. | Am J Physiol Cell Physiol | 2024 | 38646785 | PubTator, text mining | PubMed |
| Correction: Crespo et al. Protective Effect of Protocatechuic Acid on TNBS-Induced Colitis in Mice Is Associated with Modulation of the SphK/S1P Signaling Pathway. Nutrients 2017, 9, 288. | Nutrients | 2024 | 38542824 | PubTator, text mining | PubMed |
| Shifting from the treat-to-target to the early highly effective treatment approach in patients with multiple sclerosis - real-world evidence from Germany. | Ther Adv Neurol Disord | 2024 | 38525488 | PubTator, text mining | PubMed |
| [Comorbidities in multiple sclerosis and their influence on the choice of treatment]. | Rev Neurol | 2024 | 38482703 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8720/papers?page=12